Integral Health Asset Management, LLC
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it. Buying this fund's new positions the day each filing went public, over 24 quarters, returned +0.0% per quarter versus +3.9% from simply owning every 13F stock — it beat that baseline in only 29.2% of quarters (excess t = -2.90). Copying it would have systematically underperformed the simplest possible strategy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 86 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| INSM | $245M | | ADD |
| RVMD | $146M | | ADD |
| CYTK | $105M | | ADD |
| REGN | $66M | | TRIM |
| VERA | $64M | | TRIM |
| CAH | $57M | | ADD |
| ROIV | $55M | | ADD |
| BTSG | $53M | | ADD |
| RYTM | $52M | | ADD |
| MRK | $51M | | ADD |
| EWTX | $50M | | ADD |
| AZN | $49M | | NEW |
| ALHC | $45M | | ADD |
| NVS | $38M | | HOLD |
| BSX | $35M | | ADD |
| LFST | $27M | | ADD |
| ASND | $26M | | ADD |
| SRRK | $25M | | ADD |
| ELV | $22M | | ADD |
| CNC | $21M | | HOLD |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.